The invention also regards antibodies immunoreactive with the protein or fragments thereof and a kit comprising such an antibody and instructions for use in conducting an assay.LORENZO PilarSAXNE ToreHEINEGRD DickCartilage intermediate layer protein2C1and its use todifferentiate osteoarthritis from ...
Human Cartilage intermediate layer protein 2 (CILP2) ELISA Kit 供应商 Biomatik 产品货号 EKC33021 产品报价 ￥询价/96T 产品说明书 点击查看 购买方式 银行转账、电汇、支票、现金,在线支付宝及网银支付,或直接与我们电话联系400-6800-868。 产品新闻 ...
ChemicalBook provide Chemical industry users with Recombinant Cartilage Intermediate Layer Protein 2 (CILP2) Boiling point Melting point,Recombinant Cartilage Intermediate Layer Protein 2 (CILP2) Density MSDS Formula Use,If You also need to Recombinant C
Cartilage intermediate layer protein 1 ELISA Kit的详细说明书 检测范围: 使用:本试剂仅供科研使用 保存:2-8℃ 有效期:6个月 检测方法:ELISA 产品性状:96T/48T,盒装液体 贮藏条件:2-8°C 产品主要成分:酶标板,试剂,标准品等。 种属:马铃薯、鹿、羊、鸡、鸭、鱼、人、大鼠、小鼠、豚鼠、仓鼠、裸鼠、兔子、...
Cartilage intermediate layer protein 2 COMP: Cartilage oligomeric matrix protein CPII: Collagen synthesis marker C-propeptide of type II procollagen CTX-II: C-telopeptide of type II collagen FU: 2-year follow-up IKDC: International Knee Documentation Committee MCS: Mental Component Score ME...
tissue Chondroitin sulfate synthase 3 Hyaluronan synthase 3 Procollagen C-endopeptidase enhancer Asporin Biglycan Cartilage intermediate layer protein 2 Chondroadherin Collagen alpha 1(V) chain Collagen, type I, alpha 1 Collagen, type I, alpha 2 Collagen, type II, alpha 1 Collagen, type III, al...
接收到CILP, Control Peptide (Cartilage Intermediate Layer Protein 1, CILP-1, Cartilage Intermediate-layer Protein, UNQ602/PRO1188)产品后,置于-20°C温度下保存。 其他 Usbiological公司是美国著名的抗体和生化试剂供应商,生产世界上种类最多的抗体,用于Western Blot、免疫沉淀、免疫荧光、免疫组化和流式细胞术...
人软骨间层蛋白2(CILP2)ELISA试剂盒【Human Cartilage intermediate layer protein 2(CILP2) ELISA Kit】 价格: ￥3600/盒 产品详情:Product Name Human Cartilage intermediate layer protein 2(CILP2) ELISA Kit Chinese Name 人软骨间层蛋白2(CILP2)ELISA Kit ... 包装规格:96T 用途:仅限科研 货号:CSB-EL...
Heart failure is accompanied by extracellular matrix (ECM) remodelling, often leading to cardiac fibrosis. In the present study we explored the significance of cartilage intermediate layer protein 1 (CILP1) as a novel mediator of cardiac ECM remodelling.
The present embodiments relate to methods for determining or detecting pathological cartilage turnover by detection of Cartilage Oligomeric Matrix Protein (COMP) neoepitopes, both r